section name header

Y-Site Injection Compatibility (1:1 Mixture)

Imipenem-cilastatin sodium-relebactam

(Mfr: ME)(Conc: 5 mg/mLa,c)

QMark

Digoxin

(Conc: 250 mcg/mL)

Remarks:

Visually compatible; increased solution consistency observed

Ref:

3605